CEO in Radius Health, Danish Jesper Høiland, enjoys competing against Eli Lilly, his old rival from his time in Novo Nordisk. But he does not care much for the rivaling CEO’s view on the rising prices on medicine in the US.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.